|
|
|
|
| LEADER |
02693nmm a2200649 u 4500 |
| 001 |
EB002165342 |
| 003 |
EBX01000000000000001303121 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841212527
|
| 050 |
|
4 |
|a RM411
|
| 100 |
1 |
|
|a Martin, John C.
|e [editor]
|
| 245 |
0 |
0 |
|a Nucleotide analogues as antiviral agents
|c John C. Martin, editor
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 1989, 1989
|
| 300 |
|
|
|a 204 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Nucleotides / Synthesis
|
| 653 |
|
|
|a MEDICAL / Pharmacology / bisacsh
|
| 653 |
|
|
|a Nucleotides / chemical synthesis
|
| 653 |
|
|
|a AIDS (Disease) / Analysis
|
| 653 |
|
|
|a Antiviral Agents / pharmacology
|
| 653 |
|
|
|a Glycosylation / Inhibitors
|
| 653 |
|
|
|a Herpes simplex virus / Inhibitors
|
| 653 |
|
|
|a Heterocyclic Compounds
|
| 653 |
|
|
|a Acquired Immunodeficiency Syndrome
|
| 653 |
|
|
|a Ribavirin / analysis
|
| 653 |
|
|
|a Antiviral agents / Evaluation
|
| 653 |
|
|
|a Semliki forest virus
|
| 653 |
|
|
|a Antiviral agents / Synthesis
|
| 653 |
|
|
|a DNA viruses / Treatment
|
| 653 |
|
|
|a Nucleotides / therapeutic use
|
| 653 |
|
|
|a Reverse transcriptase / Inhibitors
|
| 653 |
|
|
|a Drug Therapy
|
| 653 |
|
|
|a Antiviral agents / Testing
|
| 653 |
|
|
|a Phosphonates / Synthesis
|
| 653 |
|
|
|a Nucleotides / pharmacology
|
| 653 |
|
|
|a Nucleotides / Derivatives / Therapeutic use / Testing
|
| 653 |
|
|
|a Semliki Forest virus / Analysis
|
| 653 |
|
|
|a Heterocyclic compounds / Derivatives
|
| 653 |
|
|
|a Ribavirin / Analysis
|
| 653 |
|
|
|a Reverse Transcriptase Inhibitors
|
| 653 |
|
|
|a Glycosylation
|
| 653 |
|
|
|a Phosphonates / chemical synthesis
|
| 653 |
|
|
|a Antiviral Agents / chemical synthesis
|
| 653 |
|
|
|a DNA Virus Infections / therapy
|
| 653 |
|
|
|a Herpes Simplex
|
| 653 |
|
|
|a Chemotherapy / Analysis
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Carbohydrate Chemistry
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Medicinal Chemistry
|
| 710 |
2 |
|
|a American Chemical Society
|b Meeting ( 1988, Los Angeles, California)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a "Developed from a symposium sponsored by the Division of Carbohydrate Chemistry and the Division of Medicinal Chemistry at the 196th National Meeting of the American Chemical Society, Los Angeles, California, September 25-30, 1988.". - Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-1989-0401
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.9/25061
|